EasyManua.ls Logo

Hologic ThinPrep 5000 - Lsil

Hologic ThinPrep 5000
27 pages
Print Icon
To Next Page IconTo Next Page
To Next Page IconTo Next Page
To Previous Page IconTo Previous Page
To Previous Page IconTo Previous Page
Loading...
MAN-04008-001 Rev. 001 Page 18 of 27
ThinPrep 2000, for the specimens with Reference Diagnosis of ASC-US+ (combined ASC-US, AGUS, LSIL,
ASC-H, HSIL, and Cancer), LSIL+ (combined LSIL, ASC-H, HSIL, and Cancer), ASC-H+ (combined ASC-H,
HSIL, and Cancer) and HSIL+ (combined HSIL and Cancer) were compared.
Clinical Study Results
Tables 20 through 23 present the comparison of Laboratory true positive and negative rates for ASC-US+,
LSIL+, ASC-H+, and HSIL+.
Table 20: Laboratory ThinPrep 5000 Results vs Laboratory ThinPrep 2000 Results for the Specimens
with Reference Diagnosis of ASC-US+
In the study, there were 530 specimens with Reference Diagnosis of ASC-US+ (combined ASC-US, AGUS,
LSIL, ASC-H, HSIL, and Cancer) and 696 specimens with Reference Diagnosis of NILM.
In this table, “Positive” means ASC-US+ or UNSAT, and “Negative” means NILM. All percentages
are rounded to the nearest 0.1%.
ASCUS+
Positive Percent Agreement Negative Percent Agreement
Lab CT/
Pathologist
ThinPrep 5000
(95% CI)
ThinPrep 2000
(95% CI)
Difference
(95% CI)
ThinPrep 5000
(95% CI)
ThinPrep 2000
(95% CI)
Difference
(95% CI)
#1
90.9%
(482/530)
(88.2% to 93.1%)
89.4%
(474/530)
(86.5% to 91.8%)
1.5%
(8/530)
(-0.7% to 3.8%)
89.1%
(620/696)
(86.5% to 91.2%)
87.9%
(612/696)
(85.3% to 90.1%)
1.1%
(8/696)
(-1.1% to 3.5%)
#2
87.0%
(461/530)
(83.8% to 89.6%)
86.6%
(459/530)
(83.4% to 89.2%)
0.4%
(2/530)
(-2.7% to 3.4%)
88.6%
(617/696)
(86.1% to 90.8%)
90.7%
(631/696)
(88.3% to 92.6%)
-2.0%
(-14/696)
(-4.4% to 0.3%)
#3
87.5%
(464/530)
(84.5% to 90.1%)
88.5%
(469/530)
(85.5% to 90.9%)
-0.9%
(-5/530)
(-3.7% to 1.8%)
87.6%
(610/696)
(85.0% to 89.9%)
88.1%
(613/696)
(85.5% to 90.3%)
-0.4%
(-3/696)
(-2.9% to 2.0%)
Table 21: Laboratory ThinPrep 5000 Results vs Laboratory ThinPrep 2000 Results for the Specimens
with Reference Diagnosis of LSIL+
In the study, there were 387 specimens with Reference Diagnosis of LSIL+ (combined LSIL, ASC-H, HSIL, and
Cancer) and 839 specimens with Reference Diagnosis of (combined NILM, ASC-US, and AGUS).
In this table, “Positive” means LSIL+ or UNSAT, and “Negative” means NILM or ASC-US/AGUS.
All percentages are rounded to the nearest 0.1%.
LSIL+
Positive Percent Agreement Negative Percent Agreement
Lab CT/
Pathologist
ThinPrep 5000
(95% CI)
ThinPrep 2000
(95% CI)
Difference
(95% CI)
ThinPrep 5000
(95% CI)
ThinPrep 2000
(95% CI)
Difference
(95% CI)
#1
84.8%
(328/387)
(80.8% to 88.0%)
86.8%
(336/387)
(83.1% to 89.8%)
-2.1%
(-8/387)
(-5.9% to 1.7%)
90.3%
(758/839)
(88.2% to 92.2%)
89.5%
(751/839)
(87.3% to 91.4%)
0.8%
(7/839)
(-1.1% to 2.8%)
#2
84.0%
(325/387)
(80.0% to 87.3%)
83.5%
(323/387)
(79.4% to 86.8%)
0.5%
(2/387)
(-3.6% to 4.6%)
91.7%
(769/839)
(89.6% to 93.3%)
91.4%
(767/839)
(89.3% to 93.1%)
0.2%
(2/839)
(-1.7% to 2.2%)
#3
84.0%
(325/387)
(80.0% to 87.3%)
87.3%
(338/387)
(83.7% to 90.3%)
-3.4%
(-13/387)
(-7.4% to 0.6%)
88.6%
(743/839)
(86.2% to 90.5%)
89.4%
(750/839)
(87.1% to 91.3%)
-0.8%
(-7/839)
(-2.9% to 1.2%)

Other manuals for Hologic ThinPrep 5000

Related product manuals